On the other hand, the SET domain containing 2 (SETD2) was associated with a low risk of CAT across cancers, and isocitrate dehydrogenase (NADP(+)) 1 (IDH1) was associated with a low risk of CAT in glioma [47,70,71]. This evidence concerns the gene SETD2 and central nervous system cancer.